| Literature DB >> 25436414 |
Kohei Yuyama1, Hui Sun2, Seigo Usuki2, Shota Sakai2, Hisatoshi Hanamatsu2, Tetsuo Mioka3, Nobuyuki Kimura4, Megumi Okada5, Hidetoshi Tahara5, Jun-ichi Furukawa6, Naoki Fujitani6, Yasuro Shinohara6, Yasuyuki Igarashi2.
Abstract
Elevated amyloid-β peptide (Aβ) in brain contributes to Alzheimer's disease (AD) pathogenesis. We demonstrated the presence of exosome-associated Aβ in the cerebrospinal fluid (CSF) of cynomolgus monkeys and APP transgenic mice. The levels of exosome-associated Aβ notably decreased in the CSF of aging animals. We also determined that neuronal exosomes, but not glial exosomes, had abundant glycosphingolipids and could capture Aβ. Infusion of neuronal exosomes into brains of APP transgenic mice decreased Aβ and amyloid depositions, similarly to what reported previously on neuroblastoma-derived exosomes. These findings highlight the role of neuronal exosomes in Aβ clearance, and suggest that their downregulation might relate to Aβ accumulation and, ultimately, the development of AD pathology.Entities:
Keywords: APP transgenic mouse; Alzheimer’s disease; Amyloid-β peptide; Cerebrospinal fluid; Cynomolgus monkey; Exosome
Mesh:
Substances:
Year: 2014 PMID: 25436414 DOI: 10.1016/j.febslet.2014.11.027
Source DB: PubMed Journal: FEBS Lett ISSN: 0014-5793 Impact factor: 4.124